Skip to content

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

nejm.org
2 pointsrenerthr1 comment
On HN

Comments

Does anyone with a medical background know how a drug with such performance would be used, if it turns out to be repeatable? According to the study, it results in slightly better outcomes than a placebo, but it's not like it's a cure or even a very strong medicine. It just helps a bit more than random. So how would one employ this? Are there other examples of drugs with similar performance being used?

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.